Logo-apb
Adv Pharm Bull. 2018;8(4): 721-725. doi: 10.15171/apb.2018.081
PMID: 30607345        PMCID: PMC6311638

Short Communication

Overcoming Poor Solubility of Dimenhydrinate: Development, Optimization and Evaluation of Fast Dissolving Oral Film

Yuvraj Govindrao Jadhav 1, Upendra Chandrakant Galgatte 1 * ORCID, Pravin Digambar Chaudhari 1

Cited by CrossRef: 9


1- RIZK M, TEAIMA M, ABDELMONEM R, EL-NABARAWI M, ELHABAL S. BI-LAMINATED ORAL DISINTEGRATING FILM FOR SYMPTOMATIC TREATMENT OF VIRAL NASOPHARYNGITIS: FORMULATION, CHARACTERIZATION, TASTE MASKING, AND STABILITY STUDIES. Int J App Pharm. 2024;:267 [Crossref]
2- Salama A, Hamed Salama A, Hasanein Asfour M. Tannic acid coated nanosuspension for oral delivery of chrysin intended for anti-schizophrenic effect in mice. International Journal of Pharmaceutics. 2024;656:124085 [Crossref]
3- Lim S, Dafydd M, Ong J, Ord-McDermott L, Board-Davies E, Sands K, Williams D, Sloan A, Heard C. Mucoadhesive thin films for the simultaneous delivery of microbicide and anti-inflammatory drugs in the treatment of periodontal diseases. International Journal of Pharmaceutics. 2020;573:118860 [Crossref]
4- de Carvalho A, Paiva N, Demonari I, Duarte M, do Couto R, de Freitas O, Vicentini F. The Potential of Films as Transmucosal Drug Delivery Systems. Pharmaceutics. 2023;15(11):2583 [Crossref]
5- Aldawsari H, Badr-Eldin S. Enhanced pharmacokinetic performance of dapoxetine hydrochloride via the formulation of instantly-dissolving buccal films with acidic pH modifier and hydrophilic cyclodextrin: Factorial analysis, in vitro and in vivo assessment. Journal of Advanced Research. 2020;24:281 [Crossref]
6- Ma Y, Guan R, Gao S, Song W, Liu Y, Yang Y, Liu H. Designing orodispersible films containing everolimus for enhanced compliance and bioavailability. Expert Opinion on Drug Delivery. 2020;17(10):1499 [Crossref]
7- Abla K, Mneimneh A, Allam A, Mehanna M. Application of Box-Behnken Design in the Preparation, Optimization, and In-Vivo Pharmacokinetic Evaluation of Oral Tadalafil-Loaded Niosomal Film. Pharmaceutics. 2023;15(1):173 [Crossref]
8- MOHANAN J, SUBRAMANIYAN G, KUTTALINGAM A, NARAYANASAMY D. IMPLEMENTING CENTRAL COMPOSITE DESIGN FOR THE DEVELOPMENT OF TACROLIMUS FILM FOR SUBLINGUAL ADMINISTRATION. Int J App Pharm. 2023;:35 [Crossref]